Dr. Reddy's Faces ₹2,395 Crore Tax Reassessment

  Published 1 year ago

Dr. Reddy's Laboratories is facing a ₹2,395.82 crore tax reassessment notice for AY 2020-21, following its merger with Dr. Reddy's Holding Limited. The company disputes the claim and expects minimal impact.

  • Tax notice issued under Section 148A.
  • Merger approved by NCLT in 2022.
  • Promoters to indemnify against liabilities.

You might like these

Indian Stocks to Rebound, Outflows a Concern

Indian Liquor Stocks Drop Amid Maharashtra Tax Hike

Alibaba & SAP Deepen AI Partnership

RBI Documentary: Unlocking India's Financial History

Zydus Wins US Nod for Celecoxib

ITI Launches AI Road Safety Pilot in UP

BHEL Q1 Loss Widens Despite Flat Revenue

News that matters the most ⚡